Our strategy Our current strategic period started in 2021, setting out our vision and goals to achieve testing for healthy and safe lives.
ACT-Accelerator We co-convene the diagnostics pillar of this global collaboration to ensure access to COVID-19 tests for everyone, everywhere.
G20 in India We are highlighting the importance of diagnostics in ensuring that the G20 health priorities are achieved.
100 Days Mission A plan for the world to be able to respond to and extinguish the global threat of the next Disease X within 100 days of WHO declaring a major outbreak or pandemic.
Diagnostics & IP Find out how intellectual property rights are protected in the diagnostics industry.
Press release FIND and Republic of Indonesia Ministry of Health ink partnership to drive access to essential diagnostic tests
DxConnect Tools and resources provided under the DxConnect umbrella contain information managed and collated – but not owned – by FIND, as a service to the diagnostics community.
Data for decisions Diagnostics provide critical information for healthcare professionals, decision-makers, and people living with diseases and health conditions.
The diagnostic journey From R&D to implementation, the diagnostic value chain can be thought of as a journey of interconnected steps, or a "virtuous cycle".
Diagnostics Commission The Lancet Commission on diagnostics was published in 2021, putting forward recommendations to accelerate and transform access to diagnostics globally.
Webinar Strengthening diagnostics capacity: can a WHA Resolution catalyze change? The Lancet Commission on diagnostics 26 Apr 2023
Conflict-affected settings present specific challenges for diagnostic testing Fast, accurate and reliable diagnostics are an essential component of the health response in conflict-affected settings and emergency situations.
New routes to market for diagnostic manufacturers can expand access to testing The DxConnect marketplace was conceived by FIND to directly connect buyers with approved test suppliers to serve market segments that cannot access quality products through other procurement mechanisms.
Self-tests and self-care empower people to take control of their health, and protect themselves and their communities FIND is building a self-testing resource hub to share our learnings and experiences around the introduction of self-testing technologies, examples of implementation tools, and case studies.
Lessons from innovations and positive outliers in diagnostic service delivery can be leveraged to inform policy and practice Experts, funders, and partners are coming together to identify innovations and country-level diagnostic programmes that are contributing to closing the gap in delivering diagnostic services.
Language choices and terminology can impact health-seeking behaviour Working with communities we are aiming to create an open-access language guide specific to diagnostic testing, which can encourage thoughtful and accurate communications as a complement to existing disease-specific language guides.
Diagnostics are an essential enabler of vaccine development, and effective and efficient vaccination campaigns Diagnostics can lead to better value for money in efforts to prevent disease through vaccination.
Intellectual property is a hotly debated topic in healthcare The pharmaceutical and vaccines industries both make regular use of patents to protect their innovative products but, in many cases, patents are less consequential for diagnostic tests due to their unique nature.
